Biomarker derived risk scores predict venous thromboembolism and major bleeding among patients with COVID-19.
Scott C WollerScott M StevensJoseph R BledsoeMasarret FaziliJames F LloydGreg L SnowBenjamin D HornePublished in: Research and practice in thrombosis and haemostasis (2022)
The HA-VTE IMRS and HA-MB IMRS predict 90- and 30-day VTE and major bleeding among COVID-19 patients. Adding D-dimer improved the predictiveness of the HA-VTE IMRS for VTE.